Specialty Pharmacy

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) are now lower by 70 percent over the past three months. Analysts at Deutsche Bank and Morgan Stanley both raised concerns on the company's business. Gregg Gilbert of Deutsche Bank noted a propriety survey with doctors indicated...

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were higher by 6 percent late Monday morning. Notable short-seller Citron Research said that it will not "dial back warnings" on Valeant. Citron said that it also "stands by" its Enron analogy and that Valeant has...

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were trading lower by more than 10 percent early Monday morning. The Wall Street Journal reported over the weekend that the relationship between Valeant and specialty pharmacies are "more intertwined than though." Valeant...